AHFS Drug Information
13th May 2026
AHFS Drug Information
This update contains 4 new monographs and 43 revised monographs….
AHFS Drug Information
Evaluative evidence-based guidance for safe and effective drug therapy
Published by the American Society of Health-System Pharmacists (ASHP), AHFS Drug Information is a dependable, comprehensive, and objective database for drug products approved by the FDA.
The American Hospital Formulary Service (AHFS) drug information database is maintained and updated continuously throughout the year.
The inclusion of evidence-based data on licensed and unlicensed drug use makes this a valuable reference for health professionals seeking to provide their patients with safe and effective therapy.
- 96k+
- Uniquely cited references
- 62k+
- Supporting evidence sources
- 500+
- Peer reviews
- 64+
- Years since first published
Ensure safe and effective medication use
Highly detailed monographs to support clinical practice
Critical, evidence-based evaluation of relevant clinical data
Compiled without influence from manufacturers, insurers and regulators
Full spectrum of drug therapy including dose, use, pharmacology, safety and pharmacokinetics
Covers licensed and off-licensed usage of medicines
Comprehensive database of prescription and over-the-counter drugs, alternative therapies and supplements
Expertly curated content from AHSP
Latest knowledge updates
13th May 2026
AHFS Drug Information
This update contains 4 new monographs and 43 revised monographs.
New monographs: Difamilast; Milsaperidone; Navepegritide; Pegzilarginase-nbln.
Revised monographs: Antihemophilic Factor (Recombinant), Single chain; Benazepril Hydrochloride; Brexanolone; Colesevelam Hydrochloride; Concizumab-mtci; Desmopressin Acetate; DOPamine Hydrochloride; Elagolix Sodium, Estradiol, and Norethindrone Acetate; Ertapenem Sodium; Estradiol; Estrogen-Progestin Combinations; Estrogens, Conjugated, USP; Estrogens, Esterified; Estropipate; Fam-Trastuzumab Deruxtecan-nxki; Fosinopril Sodium; Insulin Glulisine; Insulin Human; levOCARNitine; Levodopa/Carbidopa; Lonapegsomatropin-tcgd; Meropenem; Meropenem and Vaborbactam; metroNIDAZOLE (Systemic); metroNIDAZOLE (Topical); Nerandomilast; Nicotine; NIFEdipine; niMODipine; Nintedanib Esylate; Nipocalimab-aahu; Ondansetron Hydrochloride; Perindopril Erbumine; Plazomicin Sulfate; Pramlintide Acetate; Quinapril Hydrochloride; Quinupristin and Dalfopristin; Ruxolitinib Phosphate (Topical); Selumetinib Sulfate; Tarlatamab-dlle; Tazemetostat Hydrobromide; Trandolapril; Valoctocogene Roxaparvovec-rvox; Verapamil Hydrochloride.
Click to close
14th April 2026
AHFS Drug Information
This update contains 7 new monographs and 32 revised monographs….
14th April 2026
AHFS Drug Information
This update contains 7 new monographs and 32 revised monographs.
New monographs: Carbachol and Brimonidine Tartrate; Copper Histidinate; Narsoplimab-wuug; Tradipitant.
Revised monographs: amLODIPine; Captopril; Cefuroxime; Clevidipine; cloNIDine; Codeine; Corticotropin, Repository; Cosibelimab-ipdl; Dasiglucagon Hydrochloride; Digoxin; dilTIAZem Hydrochloride; Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed/Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Donidalorsen Sodium; Elamipretide Hydrochloride; Eptifibatide; Felodipine; Flunisolide (Oral Inhalation); Furosemide; guanFACINE Hydrochloride; Haemophilus b Vaccine; Heparin Sodium; Hepatitis B Vaccine; Imlunestrant Tosylate; Lisinopril; Lisocabtagene Maraleucel; Losartan Potassium; MetroNIDAZOLE (systemic); Nemolizumab-ilto; NIFEdipine; Olmesartan Medoxomil; Paltusotine Hydrochloride; Pomalidomide; PONATinib Hydrochloride; Pralsetinib; Ribavirin; Risankizumab-rzaa; Sacubitril and Valsartan; SITagliptin; Sodium Nitroprusside; Tetanus and Diphtheria Toxoids Adsorbed; Tirofiban Hydrochloride; Varenicline Tartrate; Verapamil Hydrochloride; Zanubrutinib; Zenocutuzumab-zbco.
Click to close
10th March 2026
AHFS Drug Information
This update contains 7 new monographs, 37 revised monographs, and…
10th March 2026
AHFS Drug Information
This update contains 7 new monographs, 37 revised monographs, and 40
discontinued monographs.
New monographs: Aficamten; Depemokimab-ulaa; Etripamil;
Etuvetidigene Autotemcel; Ferric Maltol; Lerodalcibep-liga; Zoliflodacin
Revised monographs: AbobotulinumtoxinA; Antihemophilic Factor
(recombinant), PEGylated-aucl; Beremagene Geperpavec-svdt;
Clesrovimab-cfor; Coagulation Factor Xa (recombinant), Inactivated-zhzo;
Colchicine; Cosibelimab-ipdl; COVID-19 Vaccine, Adjuvanted (Novavax)
(2025-2026 Formula); COVID-19 Vaccine, mRNA (Moderna) (2025-2026);
COVID-19 Vaccine, mRNA (Pfizer-BioNTech) (2025-2026 Formula);
DaxibotulinumtoxinA-lanm; Denosumab; Dordaviprone Hydrochloride;
Hepatitis A Vaccine Inactivated; Human Papillomavirus Vaccine
Recombinant; Indapamide; Influenza Vaccine Inactivated; Influenza
Vaccine Live Intranasal; Influenza Vaccine Recombinant; Insulin Human;
Liothyronine Sodium; Measles, Mumps, and Rubella Virus Vaccine Live;
Meningococcal Group B Vaccine; Meningococcal Groups A, C, Y, and W-135
Vaccine; Minocycline Hydrochloride (Topical); Nintedanib Esylate;
Nirsevimab-alip; Omidubicel-onlv; Pirfenidone; Pneumococcal Vaccine;
Poliovirus Vaccine Inactivated; raNITIdine Hydrochloride; Remibrutinib;
Sebetralstat; Sodium Thiosulfate (Protectant); Valsartan; Varicella Virus
Vaccine Live.
Discontinued Monographs: Adefovir Dipivoxil; Amifostine; Amino Acid
Injections; Amobarbital Sodium; Amphetamines General Statement;
Bezlotoxumab; Cefepime Hydrochloride and Enmetazobactam;
Chikungunya Vaccine Live; Chikungunya Vaccine, Recombinant; Codeine
(Antitussive); Dolasetron Mesylate; Electrolyte Solutions; Enfuvirtide;
Ergoloid Mesylates; Ethotoin; Fat Emulsions; Fenoldopam Mesylate;
Gemifloxacin Mesylate; Gentian Violet; Gepirone Hydrochloride; Green
Soap; Histoplasmin; Irrigating Solutions; Levamlodipine Maleate;
Lodoxamide Tromethamine; Measles Virus Vaccine Live; Multivitamins;
Mumps Virus Vaccine Live; Obeticholic Acid; Oliceridine Fumarate;
Oxandrolone; Ozenoxacin; Palivizumab; Pancuronium Bromide;
Pentazocine; Peritoneal Dialysis Solutions; Retapamulin; Rubella Virus
Vaccine Live; Thyroid; Thyroid Agents General Statement.
Click to close
10th February 2026
AHFS Drug Information
This update contains 6 new monographs and 38 revised monographs….
10th February 2026
AHFS Drug Information
This update contains 6 new monographs and 38 revised monographs.
New monographs: Indapamide; Onasemnogene Abeparvovec-brve;
Plozasiran Sodium; Sevabertinib; Sibeprenlimab-szsi; Ziftomenib.
Revised monographs: AHFS Drug Information® Users Guide; Anacaulase-
bcdb; Atidarsagene Autotemcel; Brexucabtagene Autoleucel; Captopril;
Copyright and Notices; Dolasetron Mesylate; Donislecel-jujn; Editorial
Staff; Fingolimod Hydrochloride; Fluorouracil (Systemic); Ganaxolone;
Inavolisib; Isradipine; Lebrikizumab-lbkz; Lenacapavir Sodium; Leniolisib
Phosphate; Lithium; Meningococcal Group B Vaccine; Meningococcal
Groups A, C, Y, and W-135 Vaccine; Nadofaragene Firadenovec-vncg;
NIFEdipine; Nisoldipine; Ofatumumab; Onasemnogene Abeparvovec-xioi;
Pancuronium Bromide; Penpulimab-kcqx; Perfluorohexyloctane; Preface;
Rilzabrutinib; Selenious Acid; Sparsentan; Sunvozertinib; Taurolidine and
Heparin Sodium; Teclistamab-cqyv; Tislelizumab-jsgr; Verapamil
Hydrochloride; Zavegepant Hydrochloride.
Click to close
13th January 2026
AHFS Drug Information
This update contains 4 new monographs and 67 revised monographs….
13th January 2026
AHFS Drug Information
This update contains 4 new monographs and 67 revised monographs.
New monographs: Elinzanetant;Doxecitine and Doxribtimine; Glycerol
Phenylbutyrate; Nerandomilast.
Revised monographs: Acarbose; Adefovir Dipivoxil; Alogliptin Benzoate; Anthrax
Immune Globulin IV (Human); Antimuscarinics/Antispasmodics General
Statement; Belimumab; Bictegravir Sodium, Emtricitabine, and Tenofovir
Alafenamide Fumarate; Brensocatib; Brentuximab Vedotin; Candesartan
Cilexetil; Caplacizumab-yhdp; CARBOplatin; Dehydrated Alcohol;
Delandistrogene Moxeparvovec-rokl; Dengue Vaccine Live; dilTIAZem
Hydrochloride; Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate;
Elapegademase-lvlr; Elexacaftor, Tezacaftor, and Ivacaftor; Elivaldogene
Autotemcel; Exagamglogene Autotemcel; Fexinidazole; Fremanezumab-vfrm;
Gepotidacin Mesylate; Glecaprevir and Pibrentasvir; Hepatitis A Vaccine
Inactivated; Idecabtagene Vicleucel; Imipenem and Cilastatin Sodium; Ivacaftor;
L-Glutamine; Lisocabtagene Maraleucel; Lumacaftor and Ivacaftor; Mepolizumab;
Miglitol; Nemolizumab-ilto; Nevirapine; niCARdipine Hydrochloride;
Obecabtagene Autoleucel; Obiltoxaximab; Parathyroid Hormone; Pegaspargase;
Plasminogen, Human-tmvh; Poliovirus Vaccine Inactivated; Pomalidomide;
PrabotulinumtoxinA-xvfs; Pramlintide Acetate; Proparacaine Hydrochloride
(EENT); Prothrombin Complex Concentrate (Human); Raxibacumab; Rimegepant
Sulfate; Ropeginterferon Alfa-2b-njft; Semaglutide; SITagliptin; Smallpox and
Mpox (Vaccinia) Vaccine Live; Smallpox and Mpox Vaccine Live, Non-replicating;
Sodium Bicarbonate; SORAfenib Tosylate; Tezacaftor and Ivacaftor; Thyrotropin
Alfa; Trametinib Dimethyl Sulfoxide; Treprostinil; Vanzacaftor Calcium,
Tezacaftor, and Deutivacaftor; Varenicline Tartrate (EENT); Venetoclax;
Voclosporin; Zongertinib; Zoster Vaccine Recombinant, Adjuvanted.
Click to close
9th December 2025
AHFS Drug Information
This update contains 5 new monographs and 41 revised monographs….
9th December 2025
AHFS Drug Information
This update contains 5 new monographs and 41 revised monographs.
New monographs: Donidalorsen Sodium; Elamipretide Hydrochloride;
Imlunestrant Tosylate; Paltusotine Hydrochloride; Remibrutinib.
Revised monographs: amLODIPine; Antihemophilic Factor (Recombinant), Fc-
VWF-XTEN Fusion Protein-ehtl; Azilsartan Kamedoxomil; Benznidazole;
Cabozantinib S-malate; Capsaicin; Cefuroxime; Ciltacabtagene Autoleucel;
COVID-19 Vaccine, Adjuvanted (Novavax) (2025-2026 Formula); COVID-19
Vaccine, mRNA (Moderna) (2025-2026); COVID-19 Vaccine, mRNA (Pfizer-
BioNTech) (2025-2026 Formula); Darunavir; Dexmethylphenidate and
Serdexmethylphenidate; Diazoxide Choline; Diclofenac; Digoxin; Eltrombopag;
Eptifibatide; Ergoloid Mesylates; Garadacimab-gxii; Glofitamab-gxbm; Insulin
Degludec; Insulin Human; Irbesartan; Linagliptin; Lisinopril; Losartan Potassium;
metFORMIN Hydrochloride; migALAstat Hydrochloride; Netupitant/Palonosetron
Hydrochloride, Fosnetupitant/Palonosetron Hydrochloride; Nifurtimox; Nitisinone;
Nitric Oxide; Olmesartan Medoxomil; Palivizumab; Sacubitril and Valsartan;
sAXagliptin; Tirofiban Hydrochloride; Tivozanib Hydrochloride; Tranexamic Acid;
Vandetanib.
Click to close
Request access today
Access AHFS Drug Information through MedicinesComplete today.
Contact us now for pricing and access information.
Related insights
The health profession is not just who we serve, it’s where we belong
Opens in a new window